Denmark’s government, which has been a consistent supporter of the International AIDS Vaccine Initiative for over two decades, is planning to cut its support.
Denmark has invested over 150 million kroner ($23.3 million) in IAVI since 2001, including 5 million kroner ($777,800) this year. The organization has traditionally received multiyear commitments from the government.
IAVI, a nonprofit scientific research organization, works on developing vaccines and antibodies for HIV, tuberculosis, and other emerging diseases. Funds from Denmark have primarily supported the organization’s HIV research programs, including work on developing vaccines and antibodies to prevent HIV infection, especially mother-to-child transmission.
Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
About the author
Sara Jervingsarajerving
Sara Jerving is a Senior Reporter at Devex, where she covers global health. Her work has appeared in The New York Times, the Los Angeles Times, The Wall Street Journal, VICE News, and Bloomberg News among others. Sara holds a master's degree from Columbia University Graduate School of Journalism where she was a Lorana Sullivan fellow. She was a finalist for One World Media's Digital Media Award in 2021; a finalist for the Livingston Award for Young Journalists in 2018; and she was part of a VICE News Tonight on HBO team that received an Emmy nomination in 2018. She received the Philip Greer Memorial Award from Columbia University Graduate School of Journalism in 2014.
